Onko-Gene

Critical literature watch in the molecular oncology of solid tumors

FREN

Tumor type

Thyroid Cancer

OncoTree code THYROID · 2 articles

Clinical · Molecular biology

Utility of RNA Sequencing and Immunohistochemistry for NTRK Fusion in Thyroid Carcinoma

Toda S, Kasajima R, Okubo Y, et al.

Anticancer research

This study evaluated the utility of RNA sequencing and immunohistochemistry (IHC) for detecting NTRK fusions in thyroid carcinoma, particularly those potentially missed by gene panel testing. Two patient groups were analyzed: advanced thyroid cancer cases undergoing panel testing and surgical papillary thyroid carcinoma cases screened by IHC. Results indicated that a gene panel test missed one SQSTM1-NTRK3 fusion, while pan-TRK IHC showed variable sensitivity depending on the fusion type. The study concludes that active screening for NTRK fusions is desirable, especially in patients without MAPK pathway abnormalities or with positive pan-TRK staining.

Clinical · Molecular biology

Serum-based BRAF V600E detection improves early diagnosis of papillary thyroid carcinoma: A prospective diagnostic accuracy study compared with ultrasound-guided cytology

Li Q, Lu Y, Li X, et al.

Medicine

This prospective study evaluated the clinical value of serum-based BRAF V600E mutation detection, alone and in combination with ultrasound-guided fine-needle aspiration cytology (US-FNAC), for the preoperative diagnosis of papillary thyroid carcinoma (PTC). The study included 145 patients with small thyroid nodules. Results indicated that serum BRAF V600E detection, while comparable to US-FNAC in overall performance, showed significantly higher sensitivity for papillary thyroid microcarcinoma (micro-PTC). The integration of both methods substantially improved overall diagnostic performance, suggesting a complementary approach for earlier diagnosis and better risk stratification.